Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy

Clinical trial NCT04578106 · TERMINATED

Trial details

NCT number

NCT04578106

Sponsor

Fundacio Clinic Barcelona

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2020-09-23

Primary completion

2024-07-16

Enrollment

5

View on ClinicalTrials.gov